Home | SAKK
BIG Members | Breast International Group
SAKK/Pfizer Award
SAKK Swiss Group for Clinical Cancer Research Overview | SignalHire Company Profile
PDF) Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer
Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: a randomized. - ppt download
SAKK Swiss Group for Clinical Cancer Research Overview | SignalHire Company Profile
GitHub - IDSC-io/sakk: Swiss Group for Clinical Cancer Research SAKK
Francesco Bertoni has been elected as President of the Lymphoma Project Group of Swiss Group for Clinical Cancer Research
9th Masterclass in Clinical Oncology for Residents of Oncologic Specialties: Workshops and Case Presentations – University of Ioannina
PDF) Ghielmini M, Rufibach K, Salles G, Leoncini-Franscini L, Léger-Falandry C, Cogliatti S, Fey M, Martinelli G, Stahel R, Lohri A, Ketterer N, Wernli M, Cerny T, Schmitz SFSingle agent rituximab in
CAREFOR, The Clinical Academic Cancer Research Forum
Indication Lymphome agressif à cellules B récidivant ou ... - CHUV
Swiss Group for Clinical Cancer Research (SAKK) – Life Science Zurich Business Network
SAKK Swiss Group for Clinical Cancer Research | LinkedIn
SAKK Swiss Group for Clinical Cancer Research | LinkedIn
Home | SAKK
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). - Abstract - Europe PMC
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Semantic Scholar
ZOOM SAKK 30/10 HOVON 103 Indication ... - Cancer Lausanne
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
Tweets with replies by SAKK (@SAKK_ch) / Twitter
